Corneal perforation

Kala Pharmaceuticals Receives FDA Fast Track Designation for KPI-012, a Human MSC-S Therapy for Persistent Corneal Epithelial Defect

Retrieved on: 
Wednesday, April 12, 2023
Infection, Biologics license application, Eye, Paratriathlon, Fast Track, Research, Cornea, Secretome, QID, Pain, Patient, Corneal perforation, FDA, Kala, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, BLA, KALA, Food, Safety, Pharmaceutical industry, Agency

The purpose of this designation is to help speed development of new drugs, making them available to the patient more quickly.

Key Points: 
  • The purpose of this designation is to help speed development of new drugs, making them available to the patient more quickly.
  • A company with a therapeutic candidate that receives Fast Track designation may be eligible for more frequent interactions with the FDA to discuss the product development plan.
  • Therapeutic candidates with Fast Track designation may also be eligible for priority review and accelerated approval if supported by clinical data.
  • In February 2023, Kala dosed the first patient in its CHASE (Corneal Healing After SEcretome therapy) Phase 2b trial evaluating KPI-012 for the treatment of PCED.

The Inner Circle Acknowledges Laura Barnes as a Pinnacle Life Member for her contributions to the medical field.

Retrieved on: 
Monday, March 27, 2023
Yoga, American Veterinary Medical Association, Glaucoma, University, Three-body problem, Internal medicine, Pilates, Horse, University of Missouri College of Veterinary Medicine, Lego, Medicine, Cataract, Research, Multimedia, Photography, Mouth ulcer, California Polytechnic State University, San Luis Obispo, Inner circle, Central Texas, Ophthalmology, Corneal perforation, Animal, Patient, Dog, Carcinoma, Diagnosis, American College, Veterinary medicine, Trauma, Neurology, Family, Missouri College, Cat, Feline viral rhinotracheitis, Dairy, Chemistry

AUSTIN, Texas, March 27, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Laura Barnes is acknowledged as a Pinnacle Life Member for her contributions to the medical field.

Key Points: 
  • AUSTIN, Texas, March 27, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Laura Barnes is acknowledged as a Pinnacle Life Member for her contributions to the medical field.
  • She finished an internship in ophthalmology and a residency in comparative veterinary ophthalmology at the University of Missouri College of Veterinary Medicine.
  • Dr. Barnes is a board-certified member of the American College of Veterinary Ophthalmology and has been a veterinarian for nearly two decades.
  • Dr. Barnes is a member of the American Veterinary Medical Association and the American College of Veterinary Ophthalmologists.

$1.72 Billion Amniotic Membrane Market by Product, Application, and End User - Global Opportunity Analysis and Industry Forecast, 2021-2030 - ResearchAndMarkets.com

Retrieved on: 
Monday, May 9, 2022
Health, Biotechnology, Corneal perforation, Inflammation, Lists of countries and territories, Patient, Diagnosis, Hospital, Ophthalmology, Tissue, Adoption, Income, 3D ultrasound, CAGR, Infection, Growth, Awareness, Dentistry, Pet, Health insurance, Application

The "Amniotic Membrane Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Amniotic Membrane Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.
  • On the basis of product type, the global amniotic membrane market is categorized as cryopreserved amniotic membrane and lyophilization amniotic membrane.
  • On the basis of application, the surgical wound segment accounted for a major share of the market in the global amniotic membrane market in 2020.
  • The study provides an in-depth analysis of the global amniotic membrane market, with current trends and future estimations to elucidate the imminent investment pockets

Tej Kohli Foundation Moves One Step Closer to the Regeneration of Corneal Tissue to Cure Blindness

Retrieved on: 
Friday, January 17, 2020
Surgery, Philanthropy, Biotechnology, Health, Other Philanthropy, Foundation, Optical, Other Science, Science, Medicine, Medical specialties, Clinical medicine, Eye surgery, Corneal transplantation, Corneal perforation, corneal blindness, the Tej Kohli Foundation

The biosynthetic material has the potential to seal corneal perforations and cause the regeneration of corneal tissue, which would eliminate the need for corneal transplant surgery and reduce the risk of rejection.

Key Points: 
  • The biosynthetic material has the potential to seal corneal perforations and cause the regeneration of corneal tissue, which would eliminate the need for corneal transplant surgery and reduce the risk of rejection.
  • Wendy Kohli, co-Founder of the Tej Kohli Foundation said:
    Our mission is to eliminate needless corneal blindness by 2035.
  • Whilst the thousands of corneal transplant surgeries that the Foundation funds each year transforms many lives, it is statistically impossible to eliminate corneal blindness in this way.
  • Founded in 2005, the Tej Kohli Foundation seeks to make interventions that transform individual lives.